Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas

Cancer Control

Volumn 12, Issue 1, 2005, Pages 27-35

  DeLaney, Thomas F ^a,b   Trofimov, Alexei V ^a   Engelsman, Martijn ^a   Suit, Herman D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN;

BEAM THERAPY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CYCLOTRON; EWING SARCOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LINEAR ACCELERATOR; OSTEOSARCOMA; PEROPERATIVE CARE; RADIATION DOSE; REVIEW; SOFT TISSUE SARCOMA; SYNCHROTRON;

EID: 12744280714     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480501200104     Document Type: Review

References (72)

1. Barkley HT Jr, Martin RG, Romsdahl MM, el al. Treatment of soft tissue sarcomas by preoperative irradiation and conservative surgical resection. Int J Radiat Oncol Biol Phys. 1988;14:693-699.
2. DeLaney TF, Chen GT, Mauceri TC, et al. Intraoperative dural irradiation by customized 192iridium and 90yttrium brachytherapy plaques. Int J Radiat Oncol Biol Phys. 2003;57:239-245.
3. Dunst J, Schuck A. Role of radiotherapy in Ewing tumors. Pediatr Blood Cancer. 2004;42:465-470.
4. O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359:2235-2241.
5. Scully SP, Ghert MA, Zurakowski D, et al. Pathologic fracture in osteosarcoma: prognostic importance and treatment implications. J Bone Joint Surg Am. 2002;84-A:49-57. Erratum in: J Bone Joint Surg Am. 2002;84-A:622.
6. Scully SP, Ghert MA, Zurakowski D, et al. Pathologic fracture in osteosarcoma: prognostic importance and treatment implications. J Bone Joint Surg Am. 2002;84-A:49-57. Erratum in: J Bone Joint Surg Am. 2002;84-A:622.
7. Picci P, Sangiorgi L, Bahamonde L, et al. Risk factors for local recurrences after limb-salvage surgery for high-grade osteosarcomas of the extremities. Ann Oncol. 1997;8:899-903.
8. Tepper JE, Suit HD. Radiation therapy alone for sarcoma of soft tissue. Cancer. 1985;56:475-479.
9. Sailer SL. The role of radiation therapy in localized Ewing's sarcoma. Semin Radiat Oncol. 1997;7:225-235.
10. Hug EB, Fitzek MM, Liebsch NJ, et al. Locally challenging osteo- and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation therapy using three-dimensional treatment planning. Int J Radiat Oncol Biol Phys. 1995;31:467-476.
11. Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol. 1999;175(suppl 2):57-63.
12. Harrison LB, Franzese F, Gaynor JJ, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys. 1993;27:259-265.
13. Rogers CL, Theodore N, Dickman CA, et al. Surgery and permanent 1251 seed paraspinal brachytherapy for malignant tumors with spinal cord compression. Int J Radiat Oncol Biol Phys. 2002;54:505-513.
14. Armstrong JG, Fass DE, Bains M, et al. Paraspinal tumors: techniques and results of brachytherapy. Int J Radiat Oncol Biol Phys. 1991;20:787-790.
15. Ozaki T, Hillmann A, Rube C, et al. The impact of intraoperative brachytherapy on surgery of Ewing's sarcoma. J Cancer Res Clin Oncol. 1997;123:53-56.
16. Gieschen HL, Spiro IJ, Suit HD, et al. Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2001;50:127-131.
17. Hoekstra HJ, Sindelar WF, Szabo BG, et al. Hemipelvectomy and intraoperative radiotherapy for bone and soft tissue sarcomas of the pelvic girdle. Radiother Oncol. 1995;37:160-163.
18. Nag S, Shasha D, Janjan N, et al. The American Brachytherapy Society recommendations for brachytherapy of soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 2001;49:1033-1043.
19. Suit HD, Urie M, Efird JT. Proton beams in clinical radiation therapy. In: DeVita V, Hellman S, Rosenburg, eds. Principles & Practice of Oncology Updates. Philadelphia, Pa: JB Lippincott; 1992:1-15.
20. Harrison LB, Zelefsky MJ, Armstrong JG, et al. Brachytherapy and function preservation in the localized management of soft tissue sarcomas of the extremity. Semin Radiat Oncol. 1993;3:260-269.
21. Verhey LJ. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems. Semin Radiat Oncol. 1999;9:78-98.
22. Bland KI, McCoy DM, Kinard RE, et al. Application of magnetic resonance imaging and computerized tomography as an adjunct to the surgical management of soft tissue sarcomas. Ann Surg. 1987;205:473-481.
23. Nieweg OE, Pruim J, van Ginkel RJ, et al. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med. 1996;37:257-261.
24. Bortfeld T, Burkelbach J, Boesecke R, et al. Methods of image reconstruction from projections applied to conformation radiotherapy. Phys Med Biol. 1990;35:1423-1434.
25. Lomax AJ, Bortfeld T, Goitein G, et al. A treatment planning intercomparison of proton and intensity modulated photon radiotherapy. Radiother Oncol. 1999;51:257-271.
26. Miralbell R, Lomax A, Cella L, et al. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys. 2002;54:284-289.
27. Miller DW. A review of proton beam radiation therapy. Med Phys. 1995;22:1943-1954.
28. Convery DJ, Rosenbloom ME. The generation of intensity-modulated fields for conformal radiotherapy by dynamic collimation. Phys Med Biol. 1992;37:1359-1374.
29. Bilsky MH, Yamada Y, Venice KM, et al. Intensity-modulated stereotactic radiotherapy of paraspinal tumors: a preliminary report. Neurosurgery. 2004;54:823-830; discussion 830-821.
30. Loeffler JS, Siddon RL, Wen PY, et al. Stereotactic radiosurgery of the brain using a standard linear accelerator: a study of early and late effects. Radiother Oncol. 1990;17:311-321.
31. Goitein M, Abrams M, Rowell D. Multi-dimensional treatment planning II: beam's eye view, back projection, and projection through CT sections. Int J Radiat Oncol Biol Phys. 1983;9:789-797.
32. Kai J, Shiomi H, Sasama T, et al. Optical high-precision three-dimensional position measurement system suitable for head motion tracking in frameless stereotactic radiosurgery. Comput Aided Surg. 1998;3:257-263.
33. Ryu SI, Chang SD, Kim DH, et al. Image-guided hypo-fractionated stereotactic radiosurgery to spinal lesions. Neurosurgery. 2001;49:838-846.
34. Nag S, ed. High Dose Rate Brachytherapy: A Textbook. Armonk, NY: Futura Publishing Co; 1994.
35. Nag S, Orton C. Development of intraoperative high dose rate brachytherapy for treatment of resected tumor beds in anesthetized patients. Endocuriether Hypertherm Oncol. 1993;9:187-193.
36. Wilson RR. Radiological uses of fast protons. Radiology. 1946;47:487-491.
37. Austin-Seymour M, Munzenrider J, Goitein M, et al. Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of skull. J Neurosurg. 1989;70:13-17.
38. Munzenrider JE. Proton therapy for uveal melanomas and other eye lesions. Strahlenther Onkol. 1999;175(suppl 2):68-73.
39. Loeffler JS, Smith AR, Suit HD. The potential role of proton beams in radiation oncology. Semin Oncol. 1997;24:686-695.
40. Shipley WU, Verhey LJ, Munzenrider JE, et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys. 1995;32:3-12.
41. Matsuzaki Y, Osuga T, Chiba T, et al. New, effective treatment using proton irradiation for unresectable hepatocellular carcinoma. Intern Med. 1995;34:302-304.
42. Bush DA, Slater JD, Bonnet R, et al. Proton-beam radiotherapy for early-stage lung cancer. Chest. 1999;116:1313-1319.
43. Hall EJ. Radiobiology for the Radiologist. 3rd ed. Philadelphia, Pa: Lippincott; 1988.
44. Schoenthaler R, Castro JR, Petti PL, et al. Charged particle irradiation of sacral chordomas. Int J Radiat Oncol Biol Phys. 1993;26:291-298.
45. Kamada T, Tsujii H, Tsuji H, et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol. 2002;20:4466-4471.
46. Schulz-Ertner D, Nikoghosyan A, Thilmann C, et al. Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys. 2004;58:631-640.
47. Chan MF, Chui CS, Schupak K, et al. The treatment of large extraskeletal chondrosarcoma of the leg: comparison of IMRT and conformal radiotherapy techniques. J Appl Clin Med Phys. 2001;2:3-8.
48. Hong L, Alektiar KM, Hunt M, et al. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh. Int J Radiat Oncol Biol Phys. 2004;59:752-759.
49. Millar BM, Bragg CM, Conway J, et al. Investigation of the use of intensity modulated radiotherapy (IMRT) in comparison with conformal radiotherapy in the management of soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2001;51S1:412.
50. Lee N, Chuang C, Quivey JM, et al. Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 2002;53:630-637.
51. Weber DC, Trofimov AV, DeLaney TF, et al. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. Int J Radiat Oncol Biol Phys. 2004;58:1596-1606.
52. Lomax AJ, Boehringer T, Coray A, et al. Intensity modulated proton therapy: a clinical example. Med Phys. 2001;28:317-324.
53. Alektiar KM, Leung D, Zelefsky MJ, et al. Adjuvant brachytherapy for primary high-grade soft tissue sarcoma of the extremity. Ann Surg Oncol. 2002;9:48-56.
54. Janjan NA, Yasko AW, Reece GP, et al. Comparison of charges related to radiotherapy for soft-tissue sarcomas treated by preoperative external-beam irradiation versus interstitial implantation. Ann Surg Oncol. 1994;1:415-422.
55. Alektiar KM, Hu K, Anderson L, et al. High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys. 2000;47:157-163.
56. Petersen IA, Haddock MG, Donohue JH, et al. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys. 2002;52:469-475.
57. Thames HD Jr, Withers HR, Peters LJ, et al. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys. 1982;8:219-226.
58. Rosenberg AE, Nielsen GP, Keel SB, et al. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol. 1999;23:1370-1378.
59. Terahara A, Niemierko A, Goitein M, et al. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys. 1999;45:351-358.
60. Hug EB, Loredo LN, Slater JD, et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg. 1999;91:432-439.
61. Austin-Seymour M, Munzenrider JE, Goitein M, et al. Progress in low-LET heavy particle therapy: intracranial and paracranial tumors and uveal melanomas. Radiat Res Suppl. 1985;8:S219-226.
62. Isacsson U, Hagberg H, Johansson KA, et al. Potential advantages of protons over conventional radiation beams for paraspinal tumours. Radiother Oncol. 1997;45:63-70.
63. Nowakowski VA, Castro JR, Petti PL, et al. Charged particle radiotherapy of paraspinal tumors. Int J Radiat Oncol Biol Phys. 1992;22:295-303.
64. Marcus KC, Grier HE, Shamberger RC, et al. Childhood soft tissue sarcoma: a 20-year experience. J Pediatr. 1997;131:603-607.
65. Smith AR, Loeffler JS, Adams JA, et al. The potential for proton therapy to improve clinical outcomes: comparisons of proton and x-ray treatment plans for the purpose of tumor dose escalation and/or reduction of treatment-related morbidity. Int J Radiat Oncol Biol Phys. 2000;48(S):338.
66. Kuttesch JF Jr, Wexler LH, Marcus RB, et al. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol. 1996;14:2818-2825.
67. Koshy M, Landry JC, Lawson JD, et al. Potential for toxicity reduction using intensity modulated radiation therapy (IMRT) for retroperitoneal sarcoma. Int J Radiat Oncol Biol Phys. 2003;57(2 suppl):S448-S449.
68. O'Sullivan B, Davis A, Turcotte R, et al. Five-year results of a randomized phase III trial of pre-operative vs post-operative radiotherapy in extremity soft tissue sarcoma. Proc Annu Meet Am Soc Clin Oncol. 2004;22:145. Abstract 9007.
69. Suit HD, Goitein M. Dose-limiting tissues in relation to types and location of tumours: implications for efforts to improve radiation dose distributions. Eur J Cancer. 1974;10:217-224.
70. Glimelius B, Isacsson U, Blomquist E, et al. Potential gains using high-energy protons for therapy of malignant tumours. Acta Oncol. 1999;38:137-145.
71. DeLaney TF, Smith AR, Lomax A, et al. Proton beam radiation therapy. Principles & Practice of Oncology Updates. Philadelphia, Pa: JB Lippincott; 2003;17:1-10.
72. Sisterson J. Particles Newsletter. July 2004(34):1-12.